Trials / Unknown
UnknownNCT06038110
Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era
Use of Axillary Ultrasound to Guide Breast Cancer Management in the Genomic Assay Era: A Retrospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- KK Women's and Children's Hospital · Other Government
- Sex
- Female
- Age
- 21 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to determine if axillary ultrasound can reliably distinguish between patients with limited or high nodal burden, so that the patients with limited nodal burden can potentially avoid chemotherapy and instead receive upfront surgery followed by gene assay testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | axillary ultrasound | usefulness of axillary ultrasound in predicting need for chemotherapy or upfront surgery |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2023-09-14
- Last updated
- 2023-09-14
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT06038110. Inclusion in this directory is not an endorsement.